Suppression of cytokine-induced expression of endothelin-1 by dexamethasone in human retinal pigment epithelial cells

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Udono Fujimori, Reiko ^a   Totsune, Kazuhito ^b   Murakami, Osamu ^a   Arihara, Zenei ^a   Kikuchi, Kumi ^a   Tamai, Makoto ^a   Shibahara, Shigeki ^a   Takahashi, Kazuhiro ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokine; Dexamethasone; Endothelin; Eye; Inflammation; Retina

Indexed keywords

CYTOKINE; DEXAMETHASONE; ENDOTHELIN 1; GAMMA INTERFERON; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; CELL ACTIVATION; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PIGMENT EPITHELIUM; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS; CELL LINE; CYTOKINES; DEXAMETHASONE; ENDOTHELIN-1; EPITHELIAL CELLS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1BETA; PIGMENT EPITHELIUM OF EYE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 11144304196     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166311.53506.dd     Document Type: Conference Paper

References (21)

1. Takahashi K, Brooks RA, Kanse SM, et al. Production of endothelin 1 by cultured bovine retinal endothelial cells and presence of endothelin receptors on associated pericytes. Diabetes. 1989;38:1200-1202.
2. Udono T, Takahashi K, Nakayama M, et al. Induction of adrenomedullin by hypoxia in cultured retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2001;42:1080-1086.
3. Eichhorn M, Lutjen-Drecoll E. Distribution of endothelin-like immunoreactivity in the human ciliary epithelium. Curr Eye Res. 1993;12:753-757.
4. Ripodas A, de Juan JA, Roldan-Pallares M, et al. Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes. Brain Res. 2001;912:137-143.
5. Haefliger IO, Flammer J, Luscher TF. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest Ophthalmol Vis Sci. 1992;33:2340-2343.
6. MacCumber MW, Jampel HD, Snyder SH. Ocular effects of the endothelins: abundant peptides in the eye. Arch Ophthalmol. 1991;109:705-709.
7. Haque MS, Sugiyama K, Tanifuchi T, et al. Effects of BQ-123, an ETA receptor-selective antagonist, on changes of intraocular pressure, blood-aqueous barrier and aqueous prostaglandin concentrations caused by endothelin-1 in rabbit. Jpn J Ophthalmol. 1996;40:26-32.
8. Shoji N, Oshika T, Masuda K. Inflammatory reaction via arachidonic acid cascade after intravitreal injection of endothelin-1. Curr Eye Res. 1998;17:205-210.
9. Shoji N, Oshika T, Amano S, et al. Effects of endothelin receptor antagonists on anterior chamber inflammation induced by intravitreal injection of endothelin-1. Exp Eye Res. 1999;69:437-444.
10. Takahashi K, Udono-Fujimori R, Totsune K, et al. Suppression of cytokine-induced expression of adrenomedullin and endothelin-1 by dexamethasone in T98G human glioblastoma cells. Peptides. 2003;112:95-101.
11. Prasanna G, Dibas A, Tao W, et al. Regulation of endothelin-1 in human non-pigmented ciliary epithelial cells by tumor necrosis factor-alpha. Exp Eye Res. 1998;66:9-18.
12. Kanse SM, Takahashi K, Lam HC, et al. Cytokine stimulated endothelin release from endothelial cells. Life Sci. 1991;48:1379-1384.
13. Woods M, Wood EG, Bardswell SC, et al. Role for nuclear factor-kappaB and signal transducer and activator of transcription 1/ interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells. Mol Pharmacol. 2003;64:923-931.
14. Takahashi K, Ghatei MA, Jones PM, et al. Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors. J Clin Endocrinol Metab. 1991;72:693-699.
15. Takahashi K, Totsune K, Imai Y, et al. Plasma concentrations of immunoreactive-endothelin in patients with chronic renal failure treated with recombinant human erythropoietin. Clin Sci. 1993;84:47-50.
16. Takahashi K, Jones PM, Kans SM, et al. Endothelin in the gastrointestinal tract: Presence of endothelinlike immunoreactivity, endothelin-1 messenger RNA, endothelin receptors, and pharmacological effect. Gastroenterology. 1990;99:1660-1667.
17. Zhang X, Krishnamoorthy RR, Prasanna G, et al. Dexamethasone regulates endothelin-1 and endothelin receptors in human non-pigmented ciliary epithelial (HNPE) cells. Exp Eye Res. 2003;76:261-272.
18. Udono T, Takahashi K, Nakayama M, et al. Adrenomedullin in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:1962-1970.
19. Udono-Fujimori R, Udono T, Totsune K, et al. Adrenomedullin in the eye. Regulat Pept. 2003;112:95-101.
20. Takahashi K. Adrenomedullin from a pheochromocytoma to the eye: implications of the adrenomedullin research for endocrinology in the 21st century [review]. Tohoku J Exp Med. 2001;193:79-114.
21. Tezel G, Kass MA, Kolker AE, et al. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma. 1997;6:83-89.